Skip to main content


FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns

By Kaiser Health News  
   November 05, 2019

Recent news reports have focused public attention on poor quality control and contamination in the manufacturing of cheap generic drugs, particularly those made overseas. But even some of the newest, most expensive brand-name medicines have been plagued by quality and safety concerns during production, a Kaiser Health News analysis shows.

Full story

Tagged Under:

Get the latest on healthcare leadership in your inbox.